CD47 and neoplasm: Therefore, disrupting the CD47/SRIPa axis via monoclonal antibodies switches and re-educates TAMs from the tumor-promoting phenotype into the pro-inflammatory M1-like phenotype with enhanced phagocytotic behavior [91,92].